Resumo:
En
|
Texto:
En
|
PDF:
En
Abstract Background Epidermolysis bullosa (EB) is a group of rare hereditary diseases, characterized by fragility of the skin and mucous membranes. Epidemiological data on EB in Brazil are scarce. Objectives To describe epidemiological aspects of patients with EB diagnosed in the Dermatology Department of a tertiary hospital, from 2000 to 2022. Methods An observational and retrospective study was conducted through the analysis of medical records. The evaluated data included clinical form, sex, family history, consanguinity, age at diagnosis, current age, time of follow-up, comorbidities, histopathology and immunomapping, presence of EB nevi and squamous cell carcinomas (SCC), cause of and age at death. Results Of 309 patients with hereditary EB, 278 were included. The most common type was dystrophic EB (DEB), with 73% (28.4% dominant DEB, 31.7% recessive DEB and 12.9% pruriginous DEB). Other types were junctional EB with 9.4%, EB simplex with 16.5% and Kindler EB with 1.1%. Women accounted for 53% and men for 47% of cases. Family history was found in 35% and consanguinity in 11%. The mean age at diagnosis was 10.8 years and the current age was 26 years. The mean time of follow-up was nine years. Esophageal stenosis affected 14%, dental alterations affected 36%, malnutrition 13% and anemia 29%. During diagnostic investigation, 72.6% underwent histopathological examination and 92% underwent immunomapping. EB nevi were identified in 17%. Nine patients had SCC. Eleven patients died. Study limitations Insufficient data included to medical records, loss to follow-up, and unavailability of genetic testing. Conclusions In this study, dystrophic EB predominated and the need for multidisciplinary care for comorbidities and complications was highlighted. (EB diseases membranes scarce hospital 200 2022 records form sex followup, followup follow up, up immunomapping SCC, SCC , (SCC) death 30 27 (DEB) 73 28.4% 284 28 4 (28.4 317 31 7 31.7 129 12 9 12.9 DEB. . DEB) 94 9.4% 165 16 5 16.5 11 1 1.1% 53 47 cases 35 11% 108 10 8 10. 2 14 14% 36 36% 13 29 29% investigation 726 72 6 72.6 92 17 17% died testing highlighted 20 202 (SCC 3 (DEB 28.4 (28. 31. 12. 9.4 16. 1.1 72. 28. (28 9. 1. (2 (